BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
Neuropathic pain that occurs after peripheral nerve injury depends on the hyperexcitability of neurons in the dorsal horn of the spinal cord. Spinal microglia stimulated by ATP contribute to tactile allodynia, a highly debilitating symptom of pain induced by nerve injury. Signalling between microglia and neurons is therefore an essential link in neuropathic pain transmission, but how this signalling occurs is unknown. Here we show that ATP-stimulated microglia cause a depolarizing shift in the anion reversal potential (E(anion)) in spinal lamina I neurons. This shift inverts the polarity of currents activated by GABA (gamma-amino butyric acid), as has been shown to occur after peripheral nerve injury. Applying brain-derived neurotrophic factor (BDNF) mimics the alteration in E(anion). Blocking signalling between BDNF and the receptor TrkB reverses the allodynia and the E(anion) shift that follows both nerve injury and administration of ATP-stimulated microglia. ATP stimulation evokes the release of BDNF from microglia. Preventing BDNF release from microglia by pretreating them with interfering RNA directed against BDNF before ATP stimulation also inhibits the effects of these cells on the withdrawal threshold and E(anion). Our results show that ATP-stimulated microglia signal to lamina I neurons, causing a collapse of their transmembrane anion gradient, and that BDNF is a crucial signalling molecule between microglia and neurons. Blocking this microglia-neuron signalling pathway may represent a therapeutic strategy for treating neuropathic pain.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“BDNF secreted by microglia caused a shift in the neuronal anion gradient underlying neuropathic pain100.”
From Microglial signatures and their role in health and disease (2018) · cites this paper as [100]
Citations
Cites
Quantitative assessment of tactile allodynia in the rat paw
Chaplan, S. R., Bach, F. W., Pogrel, J. W., Chung, J. M., & Yaksh, T. L. (1994) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(94)90144-9 · Cited by 7,697
Microglia: a sensor for pathological events in the CNS
Kreutzberg, G. W. (1996) · Trends in Neurosciences · doi:10.1016/0166-2236(96)10049-7 · Cited by 4,396
Neuronal plasticity: Increasing the gain in pain
Woolf, C. J., & Salter, M. W. (2000) · Science · doi:10.1126/science.288.5472.1765 · Cited by 3,781
Self-citationP2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury
Tsuda, M., Shigemoto-Mogami, Y., Koizumi, S., Mizokoshi, A., Kohsaka, S., Salter, M. W., & Inoue, K. (2003) · Nature · doi:10.1038/nature01786 · Cited by 1,563
Self-citationTrans-synaptic shift in anion gradient in spinal lamina I neurons as a mechanism of neuropathic pain
Coull, J. A. M., Boudreau, D., Bachand, K., Prescott, S. A., Nault, F., Sík, A., Koninck, P. D., & Koninck, Y. D. (2003) · Nature · doi:10.1038/nature01868 · Cited by 1,118
Self-citationStreit, W. J., Walter, S. A., & Pennell, N. A. (1999) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00069-0 · Cited by 1,096
MICROGLIA AS MEDIATORS OF INFLAMMATORY AND DEGENERATIVE DISEASES
González-Scarano, F., & Baltuch, G. (1999) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.22.1.219 · Cited by 984
Ionic Mechanisms of Neuronal Excitation by Inhibitory GABA A Receptors
Staley, K. J., Soldo, B. L., & Proctor, W. R. (1995) · Science · doi:10.1126/science.7638623 · Cited by 781
Innate immunity: the missing link in neuroprotection and neurodegeneration?
Nguyen, M. D., Julien, J.-P., & Rivest, S. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn752 · Cited by 701
Intrathecal morphine inhibits substance P release from mammalian spinal cord in vivo
Yaksh, T. L., Jessell, T. M., Gamse, R., Mudge, A. W., & Leeman, S. E. (1980) · Nature · doi:10.1038/286155a0 · Cited by 697
Cited by
Items 901–1,000 of 1,006
Treating pathological pain: is KCC2 the key to the gate?
Doyon, N., Ferrini, F., Gagnon, M., & Koninck, Y. D. (2013) · Expert Review of Neurotherapeutics · doi:10.1586/ern.13.40 · Cited by 35
“In processes involving microglia, a key event is the de novo expression of the purinergic P2X4 receptors (P2X4R) in these cells at the spinal level ((15,12,3,13)).”
BackgroundInfluentialTwo-photon imaging of spinal cord cellular networks
Johannssen, H. C., & Helmchen, F. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.07.014 · Cited by 34
“Specifically, ATP-dependent signaling mechanisms have been identified (Tsuda et al., 2010), which are especially important in spinal cord injury paradigms and in models of neuropathic pain (Coull et al., 2005).”
InfluentialBrietzke, A. P., Antunes, L. D. C., Carvalho, F. M., Elkifury, J., Gasparin, A., Sanches, P. R. S., da Silva, D. P., Dussán‐Sarria, J. A., de Souza, A., Torres, I. L. D. S., et al. (2019) · Medicine · doi:10.1097/md.0000000000013477 · Cited by 46
Lee, J., Lee, G., Ko, G., & Lee, S. J. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.03.005 · Cited by 39
“Proinflammatory cytokines or BDNF derived from activated microglia lead to sensitization of the pain-transmitting neurons in the spinal cord[11; 27].”
Hu, Z., Yu, X., Chen, P., Jin, K., Zhou, J., Wang, G., Yu, J., Wu, T., Wang, Y., Lin, F., et al. (2023) · Molecular Pain · doi:10.1177/17448069231185439 · Cited by 37
“Brain-derived neurotrophic factor (BDNF) has been found to alter the anion gradient and downregulate KCC2 expression by activating the tropomyosin-related kinase B (TrkB) receptor and its downstream signaling pathways, which has been suggested to be one of the mechanisms contributing to neuropathic pain.(9) The transm…”
BackgroundTarragó, M. D. G. L., Deitos, A., Brietzke, A. P., Torres, I. L. D. S., Stefani, L. P. C., Fregni, F., & Caumo, W. (2015) · Pain Medicine · doi:10.1111/pme.12930 · Cited by 41
Tackling Chronic Pain and Inflammation through the Purinergic System
Magni, G., Riccio, D., & Ceruti, S. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867324666170710110630 · Cited by 39
“In particular, literature data showed that P2X4R-stimulated microglia released brain-derived neurotrophic factor (BDNF) as a crucial signaling factor to lamina I neurons, causing a collapse of their transmembrane anion gradient with subsequent neuronal hyperexcitability [47].”
BackgroundTerayama, R., Tabata, M., Maruhama, K., & Iida, S. (2018) · Experimental Brain Research · doi:10.1007/s00221-018-5377-1 · Cited by 37
Akhter, E. T., Griffith, R. W., ENGLISH, A. W., & Álvarez, F. J. (2019) · eNeuro · doi:10.1523/eneuro.0172-19.2019 · Cited by 33
“…signals from injured sensory afferents trigger the activation of microglia in the dorsal horn and subsequent release of BDNF that depletes KCC2 in neighboring neurons, at least in males (Tsuda et al., 2003; Coull et al., 2005; Trang et al., 2009, 2012; Beggs et al., 2012; Sorge et al., 2015).”
BackgroundInfluentialSchwann cells and trigeminal neuralgia
Liao, J.-Y., Zhou, T.-H., Chen, B.-K., & Liu, Z.-X. (2020) · Molecular Pain · doi:10.1177/1744806920963809 · Cited by 48
“Blocking the BDNF- trkB B receptor interaction has been reported to alleviate abnormal pain caused by peripheral nerve injury.(61,62) In addition, as a member of the neurotrophic factor family, BDNF can repair injured nerves.”
BackgroundMicroglia-independent peripheral neuropathic pain in male and female mice
Tu, Y., Muley, M. M., Beggs, S., & Salter, M. W. (2022) · Pain · doi:10.1097/j.pain.0000000000002643 · Cited by 36
Self-citationLee, J., Kim, S. W., & Kim, K.-T. (2022) · Cells · doi:10.3390/cells11121902 · Cited by 34
“The microglial BDNF is a critical factor of microglia–neuron crosstalk during different brain functions, as it binds to the neuronal tropomyosin-related kinase B (TrkB) receptor [89,90].”
BackgroundCentral glial activation mediates cancer-induced pain in a rat facial cancer model
Hidaka, K., Ono, K., Harano, N., Sago, T., Nunomaki, M., Shiiba, S., Nakanishi, O., Fukushima, H., & Inenaga, K. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.02.007 · Cited by 37
Dichotomy of CCL21 and CXCR3 in nerve injury-evoked and autoimmunity-evoked hyperalgesia
Schmitz, K., Pickert, G., Wijnvoord, N., Häußler, A., & Tegeder, I. (2013) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2013.04.011 · Cited by 37
“…involves phosphorylation of p38 mitogen-activated protein kinase (Mapk) Jin et al., 2003; Scholz et al., 2008; Tsuda et al., 2004, an acquisition of phagocytic properties (Liu et al., 1998), and the secretion of neurotrophic factors (Coull et al., 2005) and cytokines (DeLeo and Yezierski, 2001).”
MethodInhibiting astrocytic activation: a novel analgesic mechanism of ketamine at the spinal level?
Mei, X., Wang, W., Wang, W., Li, Y., Zhang, H., Wu, S., Li, Y.-Q., & Xu, L. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06087.x · Cited by 35
Su, D., Gu, Y., Wang, Z., & Wang, X. (2010) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e3181e9e897 · Cited by 38
“Activation of the P2X4 receptor is likely to mediate neuropathic pain by producing brain-derived neurotrophic factor in microglia.(15) MAP kinase p38, which is activated by upstream kinase MKK3/MMK6, is regarded as a stress-induced kinase and plays a critical role in inflammatory responses.”
BackgroundKim, J.-Y. V., Megat, S., Moy, J. K., Asiedu, M. N., Mejia, G. L., Vágner, J., & Price, T. J. (2016) · Pain · doi:10.1097/j.pain.0000000000000513 · Cited by 37
“A possible explanation for this is a BDNF-mediated persistent decrease in KCC2 expression and/ or function.(13) However, we failed to observe any persistent change in KCC2 protein expression in the spinal dorsal horn in this model and acetazolamide did not reverse mechanical hypersensitivity after hyperalgesic priming.”
Giardini, A. C., dos Santos, F. M., Silva, J. T. D., de Oliveira, M. E., Martins, D. O., & Chacur, M. (2017) · Pain Research and Management · doi:10.1155/2017/7429761 · Cited by 36
“These data corroborate the findings of a study by Coull et al. (2005) that demonstrated the involvement of BDNF in the generation of chronic pain and the reversal of pain after blocking the receptor for BDNF (TrkB) [13] and M’Dahoma et al. (2015) observed marked induction of microglia activation…”
BackgroundResultInfluentialThe Role of K+-Cl−-Cotransporter-2 in Neuropathic Pain
Kitayama, T. (2017) · Neurochemical Research · doi:10.1007/s11064-017-2344-3 · Cited by 36
“Brain-derived neurotrophic factor (BDNF) has been shown to change anion gradient and down-regulate KCC2 expression by activating the tropomyosin-related kinase B receptor (TrkB) receptor, and this cascade has been suggested as one of the mechanisms contributing to neuropathic pain [22].”
Ahmad, A., Afzaal, M., Saeed, F., Ali, S. W., Imran, A., Zaidi, S. Y. R., Saleem, M. A., Hussain, M., & Jbawi, E. M. A. (2023) · Cogent Food & Agriculture · doi:10.1080/23311932.2023.2226427 · Cited by 34
“In rat versions of HD driven by quinolinic acid (QA), co-treatment of minocycline (like a microglial blocker) and hesperidin dramatically increased the impact of hesperidin on neurotoxic effects brought on by QA (Coull et al. (2005).”
Tighilet, B., Dutheil, S., Siponen, M. I., & Noreña, A. J. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00281 · Cited by 32
“Indeed, the BDNF released by activated microglia has been shown to downregulate KCC2 (Coull et al., 2005; Ferrini and De Koninck, 2013).”
BackgroundIbrahim, N. M., Abdelhameed, K. M., Kamal, S. M., Khedr, E. M., & Kotb, H. I. (2017) · Pain Medicine · doi:10.1093/pm/pnx087 · Cited by 34
Barragán‐Iglesias, P., Oidor-Chan, V. H., Loeza‐Alcocer, E., Pineda-Farías, J. B., Velázquez‐Lagunas, I., Salinas-Abarca, A. B., Hong, E., Sánchez-Mendoza, A., Delgado‐Lezama, R., Price, T. J., et al. (2017) · Pharmacological Reports · doi:10.1016/j.pharep.2017.09.002 · Cited by 34
“Microglia and astrocytes could contribute to the development and maintenance of tactile allodynia as previously reported [38, 40].”
ResultDeveloping Modern Pain Therapies
Manion, J., Waller, M. A., Clark, T., Massingham, J. N., & Neely, G. G. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01370 · Cited by 39
Ferrini, F., Salio, C., Boggio, E. M., & Merighi, A. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666201116143422 · Cited by 35
“This approach has been extensively used to probe the role of endogenous BDNF in pain models, including nerve injury [103], diabetic neuropathy [172], and pain incision model [173].”
BackgroundResultInfluentialTakasaki, I., Takarada, S., Tatsumi, S., Azegami, A., Yasuda, M., Fukuchi, M., Tabuchi, A., Kondo, T., Tabuchi, Y., & Tsuda, M. (2008) · Glia · doi:10.1002/glia.20704 · Cited by 38
“Although it has been reported that ATP stimulation evokes BDNF production in microglia (Coull et al., 2005) and that ATP stimulates the expression of several genes, such as c-fos, Zif268, and Tgf-b1 in astrocytes (Hung et al., 2000; Priller et al., 1998; Wang et al., 2003), whether or not ATP…”
BackgroundSelf-citationTNF-α and Microglial Hormetic Involvement in Neurological Health & Migraine
Kraig, R. P., Mitchell, H. M., Christie-Pope, B. C., Kunkler, P. E., White, D. M., Tang, Y., & Langan, G. P. (2010) · Dose-Response · doi:10.2203/dose-response.09-056.kraig · Cited by 35
Mora, J., Cruz, O., Gala, S., & Navarro, R. (2006) · Neuro-Oncology · doi:10.1215/15228517-2006-026 · Cited by 33
In Vivo Evidence that Truncated Trkb.T1 Participates in Nociception
Renn, C. L., Leitch, C. C., & Dorsey, S. G. (2009) · Molecular Pain · doi:10.1186/1744-8069-5-61 · Cited by 33
“FL production in the spinal dorsal horn [5-9] and brainstem [10,11], leading to hyperalgesia and the formation of nocifensive behaviors.”
BackgroundDisinhibition of Mesolimbic Dopamine Circuit by the Lateral Hypothalamus Regulates Pain Sensation
Ma, Y., Zhao, W.-N., Chen, D., Zhou, D., Gao, Y., Bian, Y., Xu, Y., Xia, S.-H., Fang, T., Yang, J., et al. (2023) · Journal of Neuroscience · doi:10.1523/jneurosci.2298-22.2023 · Cited by 35
Integration of iPSC-Derived Microglia into Brain Organoids for Neurological Research
Mrza, M. A., He, J., & Wang, Y. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063148 · Cited by 34
“For instance, microglia-derived brain-derived neurotrophic factors (BDNF) not only play an essential role in transmitting neuropathic pain signals to neurons, but also lead to a shift in the anion reversal potential of spinal lamina I neurons [23].”
BackgroundMolecules to Selectively Target Receptors for Treatment of Pain and Neurogenic Inflammation
Andreev, Y. A., Vassilevski, A. A., & Kozlov, S. A. (2012) · Recent Patents on Inflammation & Allergy Drug Discovery · doi:10.2174/187221312798889266 · Cited by 37
Glial involvement in trigeminal central sensitization
Xie, Y. (2008) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2008.00801.x · Cited by 32
Ginsenosides Act As Positive Modulators of P2X4 Receptors
Dhuna, K., Felgate, M., Bidula, S. M., Walpole, S. J., Bibič, L., Cromer, B. A., Angulo, J., Sanderson, J., Stebbing, M. J., & Stokes, L. (2018) · Molecular Pharmacology · doi:10.1124/mol.118.113696 · Cited by 32
“, 2006) and in the pathophysiology associated with neuropathic pain (Tsuda et al., 2003; Coull et al., 2005).”
BackgroundInfluentialStupack, J., Xiong, X.-P., Jiang, L.-L., Zhang, T., Zhou, L., Campos, A., Ranscht, B., Mobley, W., Pasquale, E. B., Xu, H., et al. (2020) · The Journal of Neuroscience · doi:10.1523/jneurosci.0723-20.2020 · Cited by 32
“For example, BDNF secretion by activated microglia may complicate recovery by promoting neuropathic pain pathways (Coull et al., 2005; Zhang et al., 2012), and aggravate spasticity by inducing overexcitability in spinal cord motor neurons (Boyce et al.”
BackgroundAdvances in the interventional management of neuropathic pain
Varshney, V. P., Osborn, J., Chaturvedi, R., Shah, V. J., & Chakravarthy, K. V. (2021) · Annals of Translational Medicine · doi:10.21037/atm-20-6190 · Cited by 36
“The mechanism of chronic neuropathic pain, though not clearly understood, may be related to changes in anionic gradients that are associated with microglial cells (46).”
BackgroundYoo, S., Santos, C., Reynders, A., Marics, I., Malapert, P., Gaillard, S., Charron, A., Ugolini, S., Rossignol, R., Khallouqi, A. E., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109884 · Cited by 33
Nonmyocytes as electrophysiological contributors to cardiac excitation and conduction
Simón-Chica, A., Wülfers, E. M., & Köhl, P. (2023) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00184.2023 · Cited by 36
Dissociation and trafficking of rat GABAB receptor heterodimer upon chronic capsaicin stimulation
Laffray, S., Tan, K. R., Dulluc, J., Bouali‐Benazzouz, R., Calver, A. R., Nagy, F., & Landry, M. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05398.x · Cited by 33
“processes may account for sensitization in chronic pain states (Jo & Schlichter, 1999; Moore et al., 2002; Bouhassira et al., 2003; Derjean et al., 2003; Coull et al., 2005), we considered the possibility that”
BackgroundTakami, K., Fujita‐Hamabe, W., Harada, S., & Tokuyama, S. (2011) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2010.01231.x · Cited by 35
Janz, P., & Illing, R. (2014) · Journal of Neuroscience Research · doi:10.1002/jnr.23334 · Cited by 33
“…secreted depending on ERK1/2 signaling in vitro (Miao et al., 2012) by activated microglia in spinal cord slice cultures modulating synaptic potentials (Coull et al., 2005) and to stimulate Gap43 expression and regeneration of rubrospinal neurons following cervical injury (Kobayashi et al., 1997).”
BackgroundKondo, D., Saegusa, H., Yabe, R., Takasaki, I., Kurihara, T., Zong, S., & Tanabe, T. (2009) · Journal of Pharmacological Sciences · doi:10.1254/jphs.09028fp · Cited by 32
The Anti-Allodynic Gabapentinoids: Myths, Paradoxes, and Acute Effects
Alles, S. R. A., & Smith, P. A. (2016) · The Neuroscientist · doi:10.1177/1073858416628793 · Cited by 48
García-Larrea, L., & Magnin, M. (2008) · La Presse Médicale · doi:10.1016/j.lpm.2007.07.025 · Cited by 50
Gilabert, D., Duveau, A., Carracedo, S., Linck, N., Langla, A., Muramatsu, R., Koch‐Nolte, F., Rassendren, F., Grütter, T., Fossat, P., et al. (2023) · iScience · doi:10.1016/j.isci.2023.108110 · Cited by 36
“7,8 A consequence of this disinhibition is the development of a hyperexcitability of local spinal network, underlying allodynia, a hallmark of neuropathic pain.”
BackgroundThe Purinergic System and Glial Cells: Emerging Costars in Nociception
Magni, G., & Ceruti, S. (2014) · BioMed Research International · doi:10.1155/2014/495789 · Cited by 35
“Moreover, it is now emerging that bioactive molecules contained in analgesic preparation from traditional Chinese medicine (such as tetramethylpyrazine, sodium ferulate, and puerarin) can inhibit P2X3-mediated transmission in primary afferent neurons [40].”
BackgroundFrom microRNA target validation to therapy: lessons learned from studies on BDNF
Varendi, K., Mätlik, K., & Andressoo, J. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1836-z · Cited by 35
How Can Animal Models Inform on the Transition to Chronic Symptoms in Whiplash?
Winkelstein, B. A. (2011) · Spine · doi:10.1097/brs.0b013e3182387f96 · Cited by 38
Guo, L., & Schluesener, H. J. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0135-z · Cited by 36
Noise-induced hearing loss: Neuropathic pain via Ntrk1 signaling
Manohar, S., Dahar, K., Adler, H. J., Dalian, D., & Salvi, R. (2016) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2016.07.005 · Cited by 34
Kim, H., Choi, B., Lim, H., Min, H., Oh, J. H., Choi, S., Cho, J. G., Park, J., & Lee, S. J. (2017) · Molecular Pain · doi:10.1177/1744806917697006 · Cited by 32
Greenwald, J. D., & Shafritz, K. M. (2018) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2018.00018 · Cited by 39
“Further, it is unlikely that the cellular and synaptic changes associated with fear extinction occur as a result of long-term depression (LTD), as prefrontal LTD results in increased fear recovery after extinction (Herry and Garcia, 2002; Courtin et al., 2013).”
BackgroundCa2+-binding protein NECAB2 facilitates inflammatory pain hypersensitivity
Zhang, M.-D., Su, J., Ádori, C., Cinquina, V., Maleńczyk, K., Girach, F., Peng, C., Ernfors, P., Löw, P., Borgius, L., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci120913 · Cited by 34
Boakye, P. A., Rančić, V., Whitlock, K., Simmons, D. A., Longo, F. M., Ballanyi, K., & Smith, P. A. (2019) · Journal of Neurophysiology · doi:10.1152/jn.00839.2018 · Cited by 34
“…factor (BDNF) is a major harbinger of lasting increases in dorsal horn excitability that underlie this “central sensitization” (Alles and Smith 2018; Biggs et al. 2010; Coull et al. 2005; Echeverry et al. 2017; Garraway et al. 2003; Lu et al. 2009a; Smith 2014; Trang et al. 2011; Wang et al. 2009).”
BackgroundInfluentialGarcía-Fernández, P., Üçeyler, N., & Sommer, C. (2021) · PAIN Reports · doi:10.1097/pr9.0000000000000898 · Cited by 39
“Brain-derived neurotrophic factor triggers a collapse of the anion gradient in neurons through binding with TrkB, resulting in neuropathic pain.(17) In addition to p38, ERK MAPK pathway activation has also been described in early stages of neuropathic pain.”
Vacca, V., Marinelli, S., Angelis, F. D., Angelini, D. F., Piras, E., Battistini, L., Pavone, F., & Coccurello, R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094397 · Cited by 31
“In particular, microglia exert a regulatory action on NeP after nerve injury, and there is now extensive evidence that activation of CNS microglial cells is an essential part of pain hypersensitivity, as for instance for the contribution of BDNF expression in the neuron-microglia signaling system [45].”
BackgroundSerrano, P. V., Zortéa, M., Alves, R. L., Beltrán, G., Deliberali, C. B., Ramalho, L., Alves, C. F. D. S., Medeiros, L. F., Sanches, P. R. S., Silva, D. P., et al. (2022) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2022.992742 · Cited by 32
“This discovery aids in understanding how a-tDCS affects faulty neuroplasticity since it can alter mechanisms that include strengthening glutamatergic synapses while weakening GABAergic synapses (Coull et al., 2005).”
BackgroundMutations affecting glycinergic neurotransmission in hyperekplexia increase pain sensitivity
Vuilleumier, P. H., Fritsche, R., Schliessbach, J., Schmitt, B., Arendt‐Nielsen, L., Zeilhofer, H. U., & Curatolo, M. (2017) · Brain · doi:10.1093/brain/awx289 · Cited by 33
Serizawa, K., Tomizawa-Shinohara, H., Magi, M., Yogo, K., & Matsumoto, Y. (2018) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2018.03.017 · Cited by 31
Brain‐derived neurotrophic factor modulates antiretroviral‐induced mechanical allodynia in the mouse
Renn, C. L., Leitch, C. C., Lessans, S., Rhee, P. D.-Y., McGuire, W. C., Smith, B. A., Traub, R. J., & Dorsey, S. G. (2011) · Journal of Neuroscience Research · doi:10.1002/jnr.22685 · Cited by 33
“Evidence also suggests that BDNF is released from activated microglia within the SDH, which inverts the polarity of GABA-activated currents and increases excitatory activity (Coull et al., 2005).”
BackgroundRamu, J., Bockhorst, K. H. J., Grill, R. J., Mogatadakala, K. V., & Narayana, P. A. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.09.015 · Cited by 31
GT1b functions as a novel endogenous agonist of toll‐like receptor 2 inducing neuropathic pain
Lim, H., Lee, J., You, B., Oh, J. H., Mok, H. J., Kim, Y. S., Yoon, B., Kim, B. G., Back, S. K., Park, J., et al. (2020) · The EMBO Journal · doi:10.15252/embj.2019102214 · Cited by 32
“P2X4 activation of microglia, in turn, induces release of BDNF that may induce pain central sensitization by disinhibiting inhibitory synaptic transmission (Coull et al , 2005).”
Microglia: sculptors of neuropathic pain?
Ward, H. L., & West, S. J. (2020) · Royal Society Open Science · doi:10.1098/rsos.200260 · Cited by 38
“The inflammatory phenotype is thought to be mediated in part by CX3CR1 activity which drives the production of inflammatory cytokines interleukin-1β (IL-1β) and tumour necrosis factor (TNF-α) [34], whereas the release of brain-derived neurotrophic factor (BDNF) from microglia is driven by purinergic receptors P2X4 whi…”
BackgroundInfluentialOpening of BK Ca channels alters cerebral hemodynamic and causes headache in healthy volunteers
Al‐Karagholi, M. A., Ghanizada, H., Nielsen, C. A. W., Skandarioon, C., Snellman, J., López, C. L., Hansen, J. M., & Ashina, M. (2020) · Cephalalgia · doi:10.1177/0333102420940681 · Cited by 30
Purinergic Signaling in Endometriosis-Associated Pain
Trapero, C., & Martín-Satué, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228512 · Cited by 31
“Following peripheral nerve injury, P24 receptor is expressed by the microglia of the dorsal horn [109].”
BackgroundWon, K. A., Kim, M. J., Yang, K. Y., Park, J. S., Lee, M. K., Park, M. K., Bae, Y. C., & Ahn, D. K. (2013) · Journal of Pain · doi:10.1016/j.jpain.2013.10.013 · Cited by 31
Zhu, W., Frost, E. E., Begum, F., Vora, P., Au, K., Gong, Y., Macneil, B. J., Pillai, P. P., & Namaka, M. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01481.x · Cited by 36
“Further, microglia activated by peripheral nerve injury secrete high levels of BDNF which subsequently results in the development of neuropathic pain [40].”
BackgroundCentral Sensitization Versus Synaptic Long-Term Potentiation (LTP): A Critical Comment
Sandkühler, J. (2010) · Journal of Pain · doi:10.1016/j.jpain.2010.05.002 · Cited by 37
“Furthermore, conversion from inhibition to excitation anywhere along the pain pathways may also lead to exaggerated responses to A-fibre stimuli.(3,5,6) Thus, at present, nothing can be said about any heterosynaptic potentiation or synaptic scaling in pain pathways and their potential role for secondary hyperalgesia o…”
BackgroundNonneuronal Central Mechanisms of Pain
Romero-Sandoval, E. A., & Sweitzer, S. M. (2015) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2014.11.007 · Cited by 34
Role of glia in neuropathic pain
Liu, F., & Yuan, H. (2014) · Frontiers in bioscience · doi:10.2741/4247 · Cited by 29
Reischer, G., Heinke, B., & Sandkühler, J. (2020) · Molecular Pain · doi:10.1177/1744806920917249 · Cited by 31
“For example, studies reported that the brain-derived neurotrophic factor (BDNF) and its receptor TrkB is mainly expressed at peptidergic (substance P and calcitonin gene-related peptide (CGRP)) C-fibre synapses,(41,42) and BDNF caused hyperexcitability of lamina I neurons.(43) Another microglial mediator, CCL2, is als…”
BackgroundZheng, Y., Zhou, Y. H., Wu, Q., Yue, J., Ying, X., Li, S., Lou, X., Yang, G., Tu, W., Zhou, K., et al. (2020) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2020.04.020 · Cited by 30
Snapshot of microglial physiological functions
Verkhratsky, A., Sun, D., & Tanaka, J. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.104960 · Cited by 31
Cioffi, C. L. (2021) · Biomolecules · doi:10.3390/biom11060864 · Cited by 33
Fauss, G. N. K., Hudson, K. E., & Grau, J. W. (2022) · Biology · doi:10.3390/biology11020234 · Cited by 35
“In the absence of injury, BDNF downregulates KCC2 within the spinal cord, which would fuel nociceptive sensitization and the development of neuropathic pain [258,260,347,348].”
BackgroundResultWong, C., Hu, C.-Y., Lee, P., Huang, C.-C., Huang, H.-W., Huang, C., Lo, H.-T., Liu, W., & Lee, J. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02513-y · Cited by 34
Wang, Y., Liu, Y., Zhang, M., Zhou, H., Gao, Y.-H., Cheng, W., Ye, Z., Yuan, Z.-Y., Xu, G., Li, C., et al. (2022) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.2c00348 · Cited by 31
Woodburn, S. C., Asrat, H. S., Flurer, J. K., Schwierling, H. C., Bollinger, J. L., Vollmer, L. L., & Wohleb, E. S. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.01.014 · Cited by 32
M’Dahoma, S., Barthélemy, S., Tromilin, C., Jeanson, T., Viguier, F., Michot, B., Pezet, S., Hamon, M., & Bourgoin, S. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.07.026 · Cited by 29
“In addition to promoting NMDA receptor-mediated neurotransmission, BDNF is known to downregulate the expression and activity of the KCC2 K+/Cl- co-transporter, which reduces the hyperpolarizing/inhibitory properties of GABA (Coull et al., 2005).”
BackgroundRestoring ionotropic inhibition as an analgesic strategy
Bonin, R. P., & Koninck, Y. D. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.09.047 · Cited by 34
MATSUOKA, Y., & Yang, J. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.01.002 · Cited by 29
Morita, K., Kitayama, T., Morioka, N., & Dohi, T. (2008) · Pain · doi:10.1016/j.pain.2008.01.030 · Cited by 29
“Reduction of the transmembrane chloride gradient in spinal lamina I neurons contributes to the cellular hyperexcitability producing allodynia and hyperalgesia after nerve injury [7,8,43,56].”
Liang, Y., Liu, Y., Hou, B., Zhang, W., Liu, M., Sun, Y., Ma, Z., & Gu, X. (2016) · Molecular Pain · doi:10.1177/1744806916641679 · Cited by 34
“Compelling evidence suggested that BDNF is regarded as a linker molecule between neurons and glia, which plays an important role in the initiation and maintenance phase of nerve injury induced neuropathic pain or inflammatory pain, through its receptor tyrosine kinase receptor B (TrkB).(50) Moreover, in addition to CR…”
BackgroundHyperactivity, Memory Defects, and Craniofacial Abnormalities in Zebrafish fmr1 Mutant Larvae
Hu, J. M., Chen, L., Yin, J. B., Yin, H., Huang, Y., & Tian, J. (2020) · Behavior Genetics · doi:10.1007/s10519-020-09995-7 · Cited by 27
Shared mechanisms between chronic pain and neurodegenerative disease
Apkarian, A. V., & Scholz, J. (2006) · Drug Discovery Today Disease Mechanisms · doi:10.1016/j.ddmec.2006.09.006 · Cited by 29
“Brain-derived neurotrophic factor (BDNF) released from activatedmicrogliacontributestothedevelopmentofmechanical allodynia by causing a shift in the anion gradient of a subpopulation of neurons in dorsal horn lamina I so that in these neurons the normal inhibitory effect of g-aminobutyric acid (GABA) is lost [ 6 ].”
BackgroundA Comprehensive Review of the Current Status of the Cellular Neurobiology of Psychedelics
Banushi, B., & Polito, V. (2023) · Biology · doi:10.3390/biology12111380 · Cited by 37
“Therefore, a therapy focusing on both decreasing BDNF levels in the mesolimbic system and increasing BDNF levels in the hippocampus and frontal cortex could effectively treat pathological aversive motivation [166,172].”
BackgroundLin, C., Heron, P. M., Hamann, S. R., & Smith, G. M. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.04.053 · Cited by 28
“Reactive microglia within the dorsal horn are known to increase hyperexcitability of dorsal horn projection neurons by inverting the polarity of currents induced by GABA (Coull et al., 2003, 2005).”
Hayashida, K., Peters, C. M., Gutierrez, S., & Eisenach, J. C. (2011) · Journal of Pain · doi:10.1016/j.jpain.2011.09.009 · Cited by 28
“Themost likely sources of BDNF in the spinal cord after peripheral nerve injury include the terminals of primary afferents and microglia.(4,11,13,33) In normal and injured spinal cord, astrocytes can also produce BDNF.”
BackgroundDual functions of microglia in the formation and refinement of neural circuits during development
Konishi, H., Kiyama, H., & Ueno, M. (2018) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2018.09.009 · Cited by 35
“…nerve growth factor (NGF) (Elkabes et al., 1996; Frade and Barde, 1998; Nakajima et al., 2002), brain-derived neurotrophic factor (BDNF) (Elkabes et al., 1996; Nakajima et al., 2002; Morgan et al., 2004; Coull et al., 2005; Parkhurst et al., 2013), and neurotrophin-3 (NT-3) (Elkabes et al., 1996).”
Wu, Y., Shen, Z., Xu, H., Zhang, K., Guo, M., Wang, F., & Li, J. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02410-0 · Cited by 30
de Paula, T. M. H., Castro, M. S., Medeiros, L. F., Paludo, R. H., Couto, F. F., da Costa, T. R., Fortes, J., Salbego, M. D. O., Behnck, G. S., de Moura, T. A. M., et al. (2022) · Brazilian Journal of Anesthesiology (English Edition) · doi:10.1016/j.bjane.2022.08.003 · Cited by 43
Taking a bite out of spinal cord injury: do dental stem cells have the teeth for it?
Bianco, J. I., Berdt, P. D., Deumens, R., & Rieux, A. D. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-2126-5 · Cited by 30
“One way by which BDNF has been documented to contribute to central sensitisation is by creating a shift in the neuronal chloride anion gradient [266].”
BackgroundThe challenges of respiratory motor system recovery following cervical spinal cord injury
Warren, P. M., & Alilain, W. J. (2014) · Progress in brain research · doi:10.1016/b978-0-444-63488-7.00010-0 · Cited by 32
Inflammatory-induced spinal dorsal horn neurons hyperexcitability is mediated by P2X4 receptors
Aby, F., Whitestone, S., Landry, M., Ulmann, L., & Fossat, P. (2018) · PAIN Reports · doi:10.1097/pr9.0000000000000660 · Cited by 33
“Indeed, afferent nerve lesions induceactivationofmicroglial P2X4 in superficial layersof the spinal cord leading to the modification of DHN excitability.(1,2) Peripheral P2X4, expressed in macrophages and sensory neurons, are also involved in mechanical hypersensitivity in acute and chronic peripheral inflammation.”
BackgroundSapio, M. R., Iadarola, M. J., LaPaglia, D. M., Lehky, T., Thurm, A. E., Danley, K. M., Fuhr, S. R., Lee, M. D., Huey, A. E., Sharp, S. J., et al. (2019) · Pain · doi:10.1097/j.pain.0000000000001485 · Cited by 32
“BDNF secretion from glial cells has been implicated in regulating many functions related to learning and memory(55) and has been implicated in modulation of pain states.(14) Based on”
Microglia modulate the structure and function of the hippocampus after early-life seizures
Andoh, M., Ikegaya, Y., & Koyama, R. (2020) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2020.09.003 · Cited by 32
Use of low-dose naltrexone in the management of chronic pain conditions
Hatfield, E. R., Phillips, K., Swidan, S. Z., & Ashman, L. M. (2020) · The Journal of the American Dental Association · doi:10.1016/j.adaj.2020.08.019 · Cited by 27
Involvement of the BDNF–TrkB–KCC2 pathway in neuropathic pain after brachial plexus avulsion
Zhao, S., Wang, F., Wang, L., Xu, Y., Lv, L., Duan, W., Bai, R., Meng, Z., & Shao, X. (2022) · Brain and Behavior · doi:10.1002/brb3.2464 · Cited by 28
Microglial Activation Modulated by P2X4R in Ischemia and Repercussions in Alzheimer’s Disease
Castillo, C., Sáez-Orellana, F., Godoy, P. A., & Fuentealba, J. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.814999 · Cited by 29
Hippocampal plasticity after a vagus nerve injury in the rat.
(2012) · PubMed Central · doi:10.3969/j.issn.1673-5374.2012.14.003 · Cited by 23
“Since microglial activation usually increases after injury([51-56]), in this study, we evaluated the intensity of iba1, a specific marker of microglia activation.”
Background
Metadata
- Authors
- Coull, J. A. M., Beggs, S., Boudreau, D., Boivin, D., Tsuda, M., Inoue, K., Gravel, C., Salter, M. W., & De Koninck, Y.
- Affiliations
- Université Laval (CA)
- Hospital for Sick Children (CA)
- Kyushu University (JP)
- Corresponding author
- Salter, Michael W.
- Venue
- Nature
- Published
- 2005-12
- Volume
- 438
- Issue
- 7070
- Pages
- 1017-1021
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2128994172
- Cited by
- 1,965
- References
- 29
- Citations by year
- 2026: 75 · 2025: 57 · 2024: 78 · 2023: 81 · 2022: 104 · 2021: 111 · 2020: 135 · 2019: 106 · 2018: 102 · 2017: 98 · 2016: 105 · 2015: 100 · 2014: 126 · 2013: 123 · 2012: 106
- FWCI
- 37.71
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- neuropathic pain, microglia, brain-derived neurotrophic factor, TrkB receptor, ATP, mechanical allodynia, peripheral nerve injury
- MeSH terms
- Adenosine Triphosphate, Animals, Anions, Male, Membrane Potentials, Neurons, Pain, Spinal Cord, Signal Transduction, Microglia, Brain-Derived Neurotrophic Factor, Posterior Horn Cells, RNA, Small Interfering, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.